Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Sep 30;64(2):196–201. doi: 10.1136/ard.2003.019992

Prognostic laboratory markers of joint damage in rheumatoid arthritis

E Lindqvist 1, K Eberhardt 1, K Bendtzen 1, D Heinegard 1, T Saxne 1
PMCID: PMC1755350  PMID: 15458956

Abstract

Objective: To investigate whether determination of a set of laboratory markers at baseline provides prognostic information on joint damage in hands and feet in rheumatoid arthritis.

Methods: 183 patients with early rheumatoid arthritis included in a prospective study were examined. Radiographic changes in hands and feet at 5 and 10 years after inclusion were evaluated (Larsen). The markers analysed were: erythrocyte sedimentation rate (ESR); HLA-DRB alleles typed by restriction fragment length polymorphism; and C reactive protein, cartilage oligomeric matrix protein (COMP), rheumatoid factor (RF) (IgG, IgA, and IgM subtypes), antibodies against cyclic citrullinated peptide (anti-CCP), and antibodies against interleukin 1α (anti-IL1α), analysed by immunoassays. Multiple linear regression with backward elimination was used to determine the prognostic value of the variables.

Results: 117/176 patients were positive for IgG RF, 138/176 for IgA RF, 139/176 for IgM RF, 140/176 for anti-CCP, and 40/182 for anti-IL1α. After five years, ESR, the presence of IgA RF, serum COMP, and the presence of anti-CCP were significantly associated with more severe joint damage, and the presence of anti-IL1α with less severe joint damage. Baseline C reactive protein and anti-CCP predicted radiographic outcome after 10 years. A stronger prediction was obtained by combining the prognostic factors.

Conclusions: Early determination of anti-CCP, IgA RF, anti-IL-1α, ESR, C reactive protein, and COMP predicted the development of joint damage in hands and feet in this cohort. A combination of these measures reflecting different aspects of the disease process should be useful for evaluating prognosis in individual patients with early rheumatoid arthritis.

Full Text

The Full Text of this article is available as a PDF (177.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bukhari M., Lunt M., Harrison B. J., Scott D. G. I., Symmons D. P. M., Silman A. J. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum. 2002 Apr;46(4):906–912. doi: 10.1002/art.10167. [DOI] [PubMed] [Google Scholar]
  2. Combe B., Dougados M., Goupille P., Cantagrel A., Eliaou J. F., Sibilia J., Meyer O., Sany J., Daurès J. P., Dubois A. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum. 2001 Aug;44(8):1736–1743. doi: 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I. [DOI] [PubMed] [Google Scholar]
  3. Eberhardt K. B., Rydgren L. C., Pettersson H., Wollheim F. A. Early rheumatoid arthritis--onset, course, and outcome over 2 years. Rheumatol Int. 1990;10(4):135–142. doi: 10.1007/BF02274837. [DOI] [PubMed] [Google Scholar]
  4. Eberhardt K. B., Svensson B., Truedsson L., Wollheim F. A. The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis--no relationship with erosions or disease activity. J Rheumatol. 1988 Jul;15(7):1070–1074. [PubMed] [Google Scholar]
  5. Eberhardt K. B., Truedsson L., Pettersson H., Svensson B., Stigsson L., Eberhardt J. L., Wollheim F. A. Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor. Ann Rheum Dis. 1990 Nov;49(11):906–909. doi: 10.1136/ard.49.11.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eberhardt K., Fex E., Johnson U., Wollheim F. A. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis. 1996 Jan;55(1):34–39. doi: 10.1136/ard.55.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fex E., Eberhardt K., Saxne T. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet. Br J Rheumatol. 1997 Nov;36(11):1161–1165. doi: 10.1093/rheumatology/36.11.1161. [DOI] [PubMed] [Google Scholar]
  8. Forslind K., Svensson B., Svenson M., Bendtzen K. Anti-IL-1alpha autoantibodies in early rheumatoid arthritis. Scand J Rheumatol. 2001;30(3):167–168. doi: 10.1080/030097401300162950. [DOI] [PubMed] [Google Scholar]
  9. Graudal N. A., Svenson M., Tarp U., Garred P., Jurik A-G, Bendtzen K. Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome. Ann Rheum Dis. 2002 Jul;61(7):598–602. doi: 10.1136/ard.61.7.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Graudal N., Tarp U., Jurik A. G., Galløe A. M., Garred P., Milman N., Graudal H. K. Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progression. J Rheumatol. 2000 Jan;27(1):47–57. [PubMed] [Google Scholar]
  11. Hansen M. B., Andersen V., Rohde K., Florescu A., Ross C., Svenson M., Bendtzen K. Cytokine autoantibodies in rheumatoid arthritis. Scand J Rheumatol. 1995;24(4):197–203. doi: 10.3109/03009749509100873. [DOI] [PubMed] [Google Scholar]
  12. Hansen M. B., Svenson M., Abell K., Varming K., Nielsen H. P., Bertelsen A., Bendtzen K. Sex- and age-dependency of IgG auto-antibodies against IL-1 alpha in healthy humans. Eur J Clin Invest. 1994 Mar;24(3):212–218. doi: 10.1111/j.1365-2362.1994.tb00991.x. [DOI] [PubMed] [Google Scholar]
  13. Harrison B., Symmons D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford) 2000 Sep;39(9):939–949. doi: 10.1093/rheumatology/39.9.939. [DOI] [PubMed] [Google Scholar]
  14. Houssien D. A., Jonsson T., Davies E., Scott D. L. Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis. J Rheumatol. 1997 Nov;24(11):2119–2122. [PubMed] [Google Scholar]
  15. Joosten L. A., Helsen M. M., Saxne T., van De Loo F. A., Heinegard D., van Den Berg W. B. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol. 1999 Nov 1;163(9):5049–5055. [PubMed] [Google Scholar]
  16. Jouvenne P., Fossiez F., Banchereau J., Miossec P. High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study. Scand J Immunol. 1997 Oct;46(4):413–418. doi: 10.1046/j.1365-3083.1997.d01-139.x. [DOI] [PubMed] [Google Scholar]
  17. Jouvenne P., Fossiez F., Garrone P., Djossou O., Banchereau J., Miossec P. Increased incidence of neutralizing autoantibodies against interleukin-1 alpha (IL-1 alpha) in nondestructive chronic polyarthritis. J Clin Immunol. 1996 Sep;16(5):283–290. doi: 10.1007/BF01541394. [DOI] [PubMed] [Google Scholar]
  18. Kirwan J. R. The relationship between synovitis and erosions in rheumatoid arthritis. Br J Rheumatol. 1997 Feb;36(2):225–228. doi: 10.1093/rheumatology/36.2.225. [DOI] [PubMed] [Google Scholar]
  19. Kroot E. J., de Jong B. A., van Leeuwen M. A., Swinkels H., van den Hoogen F. H., van't Hof M., van de Putte L. B., van Rijswijk M. H., van Venrooij W. J., van Riel P. L. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000 Aug;43(8):1831–1835. doi: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  20. Lard L. R., Boers M., Verhoeven A., Vos K., Visser H., Hazes J. M. W., Zwinderman A. H., Schreuder G. M. T., Breedveld F. C., De Vries R. R. P. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis Rheum. 2002 Apr;46(4):899–905. doi: 10.1002/art.10151. [DOI] [PubMed] [Google Scholar]
  21. Larsen A., Dale K., Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977 Jul;18(4):481–491. doi: 10.1177/028418517701800415. [DOI] [PubMed] [Google Scholar]
  22. Larsson E., Erlandsson Harris H., Lorentzen J. C., Larsson A., Månsson B., Klareskog L., Saxne T. Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats. Rheumatology (Oxford) 2002 Sep;41(9):996–1000. doi: 10.1093/rheumatology/41.9.996. [DOI] [PubMed] [Google Scholar]
  23. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  24. Lindqvist E., Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis. 1999 Jan;58(1):11–14. doi: 10.1136/ard.58.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lindqvist E., Jonsson K., Saxne T., Eberhardt K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis. 2003 Jul;62(7):611–616. doi: 10.1136/ard.62.7.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lindqvist E., Saxne T., Geborek P., Eberhardt K. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis. 2002 Dec;61(12):1055–1059. doi: 10.1136/ard.61.12.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Matsuda Y., Yamanaka H., Higami K., Kashiwazaki S. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis. J Rheumatol. 1998 Mar;25(3):427–432. [PubMed] [Google Scholar]
  28. Meyer O., Labarre C., Dougados M., Goupille Ph, Cantagrel A., Dubois A., Nicaise-Roland P., Sibilia J., Combe B. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis. 2003 Feb;62(2):120–126. doi: 10.1136/ard.62.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mulherin D., Fitzgerald O., Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol. 1996 Dec;35(12):1263–1268. doi: 10.1093/rheumatology/35.12.1263. [DOI] [PubMed] [Google Scholar]
  30. Månsson B., Carey D., Alini M., Ionescu M., Rosenberg L. C., Poole A. R., Heinegård D., Saxne T. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest. 1995 Mar;95(3):1071–1077. doi: 10.1172/JCI117753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Möttönen T., Paimela L., Leirisalo-Repo M., Kautiainen H., Ilonen J., Hannonen P. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis. 1998 Sep;57(9):533–539. doi: 10.1136/ard.57.9.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pincus T., Ferraccioli G., Sokka T., Larsen A., Rau R., Kushner I., Wolfe F. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology (Oxford) 2002 Dec;41(12):1346–1356. doi: 10.1093/rheumatology/41.12.1346. [DOI] [PubMed] [Google Scholar]
  33. Plant M. J., Jones P. W., Saklatvala J., Ollier W. E., Dawes P. T. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol. 1998 Mar;25(3):417–426. [PubMed] [Google Scholar]
  34. Roux-Lombard P., Eberhardt K., Saxne T., Dayer J. M., Wollheim F. A. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study. Rheumatology (Oxford) 2001 May;40(5):544–551. doi: 10.1093/rheumatology/40.5.544. [DOI] [PubMed] [Google Scholar]
  35. Saxne T., Heinegård D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol. 1992 Sep;31(9):583–591. doi: 10.1093/rheumatology/31.9.583. [DOI] [PubMed] [Google Scholar]
  36. Schellekens G. A., Visser H., de Jong B. A., van den Hoogen F. H., Hazes J. M., Breedveld F. C., van Venrooij W. J. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000 Jan;43(1):155–163. doi: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  37. Schellekens G. A., de Jong B. A., van den Hoogen F. H., van de Putte L. B., van Venrooij W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998 Jan 1;101(1):273–281. doi: 10.1172/JCI1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Scott D. L. Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford) 2000 Jun;39 (Suppl 1):24–29. doi: 10.1093/oxfordjournals.rheumatology.a031490. [DOI] [PubMed] [Google Scholar]
  39. Svenson M., Hansen M. B., Kayser L., Rasmussen A. K., Reimert C. M., Bendtzen K. Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1. Cytokine. 1992 Mar;4(2):125–133. doi: 10.1016/1043-4666(92)90047-u. [DOI] [PubMed] [Google Scholar]
  40. Svenson M., Poulsen L. K., Fomsgaard A., Bendtzen K. IgG autoantibodies against interleukin 1 alpha in sera of normal individuals. Scand J Immunol. 1989 Apr;29(4):489–492. doi: 10.1111/j.1365-3083.1989.tb01149.x. [DOI] [PubMed] [Google Scholar]
  41. Teitsson I. IgA rheumatoid factor as predictor of disease activity. Scand J Rheumatol Suppl. 1988;75:233–237. doi: 10.3109/03009748809096769. [DOI] [PubMed] [Google Scholar]
  42. Vencovský J., Machácek S., Sedová L., Kafková J., Gatterová J., Pesáková V., Růzicková S. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 2003 May;62(5):427–430. doi: 10.1136/ard.62.5.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Visser H., Gelinck L. B., Kampfraath A. H., Breedveld F. C., Hazes J. M. Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis. Ann Rheum Dis. 1996 Mar;55(3):157–161. doi: 10.1136/ard.55.3.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Visser Henk, le Cessie Saskia, Vos Koen, Breedveld Ferdinand C., Hazes Johanna M. W. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002 Feb;46(2):357–365. doi: 10.1002/art.10117. [DOI] [PubMed] [Google Scholar]
  45. Young A., van der Heijde D. M. Can we predict aggressive disease? Baillieres Clin Rheumatol. 1997 Feb;11(1):27–48. doi: 10.1016/s0950-3579(97)80031-3. [DOI] [PubMed] [Google Scholar]
  46. van Leeuwen M. A., van Rijswijk M. H., Sluiter W. J., van Riel P. L., Kuper I. H., van de Putte L. B., Pepys M. B., Limburg P. C. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol. 1997 Jan;24(1):20–27. [PubMed] [Google Scholar]
  47. van Venrooij W. J., Pruijn G. J. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2000 May 24;2(4):249–251. doi: 10.1186/ar95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. van Zeben D., Breedveld F. C. Prognostic factors in rheumatoid arthritis. J Rheumatol Suppl. 1996 Mar;44:31–33. [PubMed] [Google Scholar]
  49. van den Berg W. B. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum. 2001 Apr;30(5 Suppl 2):7–16. doi: 10.1053/sarh.2001.23704. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES